维普中文期刊产品整合服务
108篇 您的检索式:作者名="STEARNS V"
    题名 作者 年代 出处 被引量
1Prognostic factors in breast cancer:current and new predictors of metastasis显示文摘HAYES D F ISAACS C STEARNS V 2001J Mammary Gland Biol Neoplasia2001,6,4:1
2When is a tumor marker ready for prime time? A case study of c-erbB-2 as a predictive factor in breast cancer显示文摘Yamauchi H Stearns V Hayes DF 2001J Clin Oncol2001,159,8:1
3Active tamoxifen metabolite plasma concentrations after coadminis- tration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine 显示文摘Stearns V Johnson MD Rae JM Morocho A Novielli A Bhargava P 2003J Natl Cancer Inst2003,95,23:1
4When is a tumor marker ready for prime time ? A case study of C-erbB-2 as a predictive factor in breast cancer显示文摘Yamauchi H Stearns V Hayes DF 2001J Clin Oncol2001,19,:1
5CYP2D6 genotype,antide-pressant use,and tamoxifen metabolism during adjuvant breast cancer treatment显示文摘Jin Y Desta Z Stearns V 2005J Natl Cancer Inst2005,97,1:1
6Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine 显示文摘Stearns V Johnson MD Rae JM 2003J Natl Cancer Inst2003,95,23:1
7Paroxetine controlled release in the treatment of menopausal hot flash-a randomized controlled trial 显示文摘Stearns V Beebe KL lyengar M 2003JAMA2003,289,21:1
8CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment 显示文摘Jin Y Desta Z Stearns V 2005J Nail Cancer Inst2005,97,1:1
9Hot flushes显示文摘Stearns V Ullmer L Lopez JF 2002Lancet2002,360,9348:1
10Pharmacogenefics in the treatment of breast cancer 显示文摘Stearns V Davidson NE Flockhart DA 2004Pharmacogenomics J2004,4,3:1
11Paroxetine controlled release in the treatment of menopausal hot flashes:a randomized controlled trial显示文摘Stearns V Beebe KL Lyengar M 2003JAMA2003,289,21:1
12Formulas for Predicting Audible Noise from Overhead High Voltage AC and DC Lines 显示文摘CHARTIER V L STEARNS R D 1981IEEE Transactions on Power Apparatus and Systems1981,100,1:1
13When is a tumour marker ready for prime time- A case study of cerbB-2 as a predictive fac-tor in breast cancer显示文摘Yamauchi H Stearns V Hayes DF 2001J CIin Oncol2001,19,8:1
14When is a tumor marker ready for prime time ? A case study of C erbB 2 as a predictive factor in breast cancer显示文摘Yamauchi H Stearns V Hayes DF 2001J Clin Oncol2001,19,:1
15Abnormal expression of REST/NRSF and Myc in neural stem/progenitor cells causes cerebellar tumors by blocking neuronal differentiation 显示文摘Su X Gopalakrishnan V Stearns D 2006Mol Cell Biol2006,26,5:1
16Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine显示文摘Stearns V Johnson MD Rae JM 2003J Natl Cancer Inst2003,95,23:1
17Clinical update:new treatment for hot flushe显示文摘Stearns V 0,,9579:1
18Active tamoxifen metabolite plasma concentrations after co administration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine 显示文摘STEARNS V JOHNSON MD RAE JM 2003J Natl Cancer Inst2003,95,23:1
19Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifcn and the se- lective serotonin reuptake inhibitor pamxetine 显示文摘Stearns V Johnson MD Rae JM 2003J Nail Cancer Inst2003,95,:1
20Is ultrasound screening for DDH in babies born breech sufficient?显示文摘Imrie M Scout V Stearns P 2010J Child Orthop2010,4,:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费